Featured

[Special Report] Trademark filing and litigation trends 2024: Insights and opportunities

Robert Reading

Director, Corporate Strategy, Content at Clarivate

Biopharma
What a string of semaglutide biosimilars could mean for Mainland China
Academia and Government
Introducing the Clarivate Academic AI Platform
Academia and Government
December 12, 2016
Academia and Government
December 8, 2016
Academia and Government
December 5, 2016
Life Sciences and Healthcare
December 1, 2016
Academia and Government
November 29, 2016
Life Sciences and Healthcare
November 28, 2016
Life Sciences and Healthcare
November 23, 2016